EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Microbiota‐Gut‐Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders

Md Faysal iD, Mehrukh Zehravi, Baishakhi Sutradhar, Md Al Amin, Thukani Sathanantham Shanmugarajan, Uppuluri Varuna Naga Venkata Arjun, Susithra Ethiraj, Akiladevi Durairaj, Girija Dayalan, Shaik Khadeer Ahamad, Safia Obaidur Rab, Kannan Raman und 1 weitere

CNS Neuroscience & Therapeutics · 2025-09 · 31 (9)

DOI: 10.1111/cns.70593 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 04.09.2025. Verfasst von Md Faysal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Mental Disorders, Nervous System Diseases, Brain. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 332 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The microbiota‐gut‐brain axis (MGBA), a complex two‐way connection between the gut microbiota and the brain, has become a key regulator of neurological and neuropsychiatric disorders. Neurological disorders and gut microbiota dysbiosis are linked to these diseases. Changes in gut microbiota can lead to neurotransmitter imbalances, oxidative stress, and neuroinflammation. Gut dysbiosis may contribute to the development of diseases such as depression, autism, schizophrenia, bipolar disorder, Parkinson's disease, Alzheimer's disease, dementia, multiple sclerosis, epilepsy, anxiety, and autism spectrum disorders through immunological regulation, neuroinflammation, and neurotransmitter metabolism changes.

Method

This review systematically sourced articles related to microbiota gut brain axis, neurological disorders, neuropsychiatric disorders and clinical studies from major medical databases, including Scopus, PubMed, and Web of Science.

Results

This review explores the molecular processes underlying MGBA interactions, including vagus nerve signaling, systemic immunological responses, and metabolites produced by microorganisms. The discussion explores the potential of microbiome‐targeted treatments like fecal microbiota transplantation, probiotics, and prebiotics as effective treatment methods. The comprehension of the MGBA can revolutionize neurology and psychiatry, introducing innovative diagnostic and therapeutic approaches. Multiple elements, including diet, metabolism, age, stress, and medications, shape the human gut microbiota, and intestinal imbalances can lead to CNS diseases. The MGBA interacts with gut bacteria, and gut dysbiosis is associated with neurological disorders.

Conclusions

The review demonstrates the correlation between gut microbiota and neurologically associated diseases, highlighting its importance in neurogenesis, mental development, emotions, and behaviors. MGBA, mediated by microbial metabolites, affects brain function and neuroinflammation. Interventions like fetal microbiota transplantation, probiotics, and prebiotics can improve microbial balance, but more clinical research is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeMental DisordersNervous System DiseasesBrainBrain-Gut AxisHumansAnimalsDysbiosisProbiotics

Stichwörter der Autor:innen

gut dysbiosismicrobiota‐gut‐brain axisneuroinflammationneurological disordersneuropsychiatric disordersprobiotics

Autor:innen und Institutionen

  • Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, Bangladesh.
  • Department of Clinical Pharmacy, College of Dentistry & Pharmacy, Buraydah Private Colleges, Buraydah, Saudi Arabia.
  • Department of Microbiology, Gono University (Bishwabidyalay), Dhaka, Bangladesh.
  • Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, Tamil Nadu, India.
  • College of Pharmacy, Sri Venkateswara University, Chennai, Tamil Nadu, India.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, Abha, Saudi Arabia.

ORCID-Profile: Md Faysal, Talha Bin Emran

Zitieren

APA

Faysal, M., Zehravi, M., Sutradhar, B., Al Amin, M., Shanmugarajan, T. S., Arjun, U. V. N. V., Ethiraj, S., Durairaj, A., Dayalan, G., Ahamad, S. K., Rab, S. O., Raman, K., & Emran, T. B. (2025). The Microbiota‐Gut‐Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders. CNS Neuroscience & Therapeutics, 31(9). https://doi.org/10.1111/cns.70593

Vancouver

Faysal M, Zehravi M, Sutradhar B, Al Amin M, Shanmugarajan TS, Arjun UVNV, et al. The Microbiota‐Gut‐Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders. CNS Neuroscience & Therapeutics. 2025;31(9). doi:10.1111/cns.70593

BibTeX
@article{Faysal2025,
  author = {Faysal, Md and Zehravi, Mehrukh and Sutradhar, Baishakhi and Al Amin, Md and Shanmugarajan, Thukani Sathanantham and Arjun, Uppuluri Varuna Naga Venkata and Ethiraj, Susithra and Durairaj, Akiladevi and Dayalan, Girija and Ahamad, Shaik Khadeer and Rab, Safia Obaidur and Raman, Kannan and Emran, Talha Bin},
  title = {The Microbiota‐Gut‐Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  volume = {31},
  number = {9},
  doi = {10.1111/cns.70593}
}
Kostenlos starten →